Davenport & Co’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$675K Buy
14,165
+20
+0.1% +$927 ﹤0.01% 896
2026
Q1
$620K Buy
14,145
+1,110
+9% +$50.7K ﹤0.01% 852
2025
Q4
$578K Buy
13,035
+272
+2% +$11.7K ﹤0.01% 855
2025
Q3
$539K Buy
12,763
+23
+0.2% +$928 ﹤0.01% 876
2025
Q2
$467K Buy
12,740
+1,197
+10% +$44.4K ﹤0.01% 899
2025
Q1
$440K Buy
11,543
+132
+1% +$4.91K ﹤0.01% 873
2024
Q4
$432K Buy
11,411
+10
+0.1% +$400 ﹤0.01% 888
2024
Q3
$464K Sell
11,401
-169
-1% -$6.39K ﹤0.01% 852
2024
Q2
$396K Buy
11,570
+14
+0.1% +$441 ﹤0.01% 875
2024
Q1
$366K Sell
11,556
-237
-2% -$7.21K ﹤0.01% 893
2023
Q4
$362K Buy
11,793
+2,350
+25% +$75.4K ﹤0.01% 858
2023
Q3
$313K Buy
9,443
+950
+11% +$30.3K ﹤0.01% 863
2023
Q2
$261K Buy
8,493
+50
+0.6% +$1.44K ﹤0.01% 938
2023
Q1
$231K Sell
8,443
-700
-8% -$19.5K ﹤0.01% 936
2022
Q4
$256K Buy
9,143
+1,200
+15% +$36.2K ﹤0.01% 865
2022
Q3
$234K Hold
7,943
﹤0.01% 880
2022
Q2
$224K Sell
7,943
-654
-8% -$18.6K ﹤0.01% 895
2022
Q1
$268K Sell
8,597
-6,353
-42% -$187K ﹤0.01% 903
2021
Q4
$442K Sell
14,950
-12,395
-45% -$362K ﹤0.01% 788
2021
Q3
$819K Buy
27,345
+3,771
+16% +$130K 0.01% 590
2021
Q2
$855K Buy
23,574
+601
+3% +$22.3K 0.01% 509
2021
Q1
$842K Buy
22,973
+16,633
+262% +$612K 0.01% 423
2020
Q4
$230K Buy
+6,340
New +$215K ﹤0.01% 715
2020
Q3
Sell
-7,872
Closed -$234K 742
2020
Q2
$234K Buy
+7,872
New +$233K ﹤0.01% 608
2020
Q1
Sell
-5,231
Closed -$222K 722
2019
Q4
$222K Buy
+5,231
New +$221K ﹤0.01% 654

Other funds holding OHI

Davenport & Co's OHI Position: Q2 2026 in Review

Davenport & Co increased its Omega Healthcare (OHI) stake by 0.14% in Q2 2026, buying an estimated $927 and bringing the position to 14,165 shares worth $675K. The position accounts for ﹤0.01% of the portfolio, ranked #896.

Davenport & Co first reported a position in OHI in Q4 2019 and has held it in 25 quarters since. The position peaked at $855K in Q2 2021. 118 funds tracked by Wall St. Rank hold OHI as of Q2 2026.

  • Davenport & Co held 14,165 shares of Omega Healthcare worth $675K as of Q2 2026.
  • Davenport & Co bought 20 Omega Healthcare shares in Q2 2026, an estimated $927.
  • Omega Healthcare made up ﹤0.01% of Davenport & Co's portfolio in Q2 2026, its #896 holding.
  • Davenport & Co first reported a position in Omega Healthcare in Q4 2019 and has held it in 25 quarters since.
  • Davenport & Co's Omega Healthcare position peaked at $855K in Q2 2021.
  • 118 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.